Kobelt, G.; Lindgren, P.; Young, A. - In: The European Journal of Health Economics 3 (2002) 3, pp. 180-187
This study investigated the cost-effectiveness of leflunomide (LEF) compared to methotrexate (MTX) and sulfasalazine (SSZ) in the United Kingdom. A Markov model was constructed using health states defined by Health Assessment Questionnaire score. The model is based on a cohort of patients with...